Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. Goyale A, Jain A, Smith C, Papatheodoridi M, et al. PLoS One 2021;16:e0260313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goyale A, Jain A, Smith C, Papatheodoridi M, et al. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. PLoS One 2021;16:e0260313.
PMID: 34813621